PedAM
Pediatric Disease Annotations & Medicines
| Disease | keratoconus |
| Phenotype | C0155135|corneal ectasia |
| Sentences | 4 |
| PubMedID- 25363069 | Context: corneal collagen cross linking (ccl) with ultraviolet a (uva) has been proposed as a treatment for the progression of corneal ectasia associated with keratoconus and post-laser-assisted in situ keratomileusis (lasik) ectasia. |
| PubMedID- 25272085 | Previous results indicate that corneal cross-linking can slow down, stabilise or even reverse the progression of corneal ectasia in patients with keratoconus as well as in patients with ectasia after excimer laser ablations. |
| PubMedID- 22254130 | Corneal collagen cross-linking (cxl) is currently under investigation to determine if it can slow, stabilize, or even possibly reverse the progression of corneal ectasia in patients with keratoconus [2]. |
| PubMedID- 22570545 | The athens protocol, in the treatment of corneal ectasia associated with keratoconus, iatrogenic ectasia, and recently severe cornea scarring.21–27 the novel treatment described herein may become an alternative to the athens protocol, serving potentially the same purpose of normalizing corneal irregularity with customized toric and spherical infrared laser cornea refractive modification and stabilizing the ectasia with combined corneal collagen cross-linking, without tissue removal or corneal thinning. |
Page: 1